Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have
relapsed or refractory low-grade non-Hodgkin's lymphoma. Thalidomide may stop the growth of
non-Hodgkin's lymphoma by stopping blood flow to the tumor